SMAD2 and hypertrophy: Furthermore, the nonpeptide analog of Ang-(1–7), AVE 0991, prevented Ang II-induced myocardial hypertrophy by putatively inhibiting the transforming growth factor (TGF)-β1/Smad2 signaling pathway [18].